<DOC>
	<DOCNO>NCT02485730</DOCNO>
	<brief_summary>The ALFA study long term , prospective , observational study AD patient ' adult child aim study characterize key physio-pathological feature preclinical phase AD .</brief_summary>
	<brief_title>Early Identification Markers Alzheimer 's Families / ALFA</brief_title>
	<detailed_description>The natural history AD include asymptomatic preclinical phase characterize pathological cerebral alteration without evident symptom disease . The begin preclinical phase detect use series biological neuroimaging marker indicate presence AÎ² deposition brain . A variety factor inflammation , genetic load ( e.g. , APOE4 ) , diet , cardiovascular risk , sleep disorder cognitive reserve , produce endogenous exogenous factor , vary among individual may determine begin evolution preclinical phase disease . It possible identify subclinical , biological , cognitive neuroimaging change , AD preclinical phase . The longitudinal study intra-individual change sensitive cross-sectional inter-individual study detect cognitive evolution AD preclinical phase . Similarly , would possible identify factor subject preclinical phase influence evolution clinical stage disease . The study start screen 3.000 recruited volunteer ( NCT01835717 ) comply much possible study selection criterion perfectly aware study need . The select 400 participant fulfil inclusion criterion undergo detailed phenotyping consisting : clinical history , AD family history , full cognitive evaluation , cognitive reserve determination , CSF sample collection , blood urine sample collection , neuroimaging ( MRI ) , quality life habit life questionnaire ( physical activity , diet , sleep habit , social activity , toxics habit , pollution exposure ) . The longitudinal study consist every 3-year follow-up visit participant undergo review clinical history data , full cognitive evaluation , neuroimaging ( MRI ) , sample collection ( blood , urine , CSF ) update life habit change .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Adult child AD patient : Firstdegree descendant AD patient ( follow diagnosis define protocol ) . Age : 45 64 year old . Longterm commitment study : baseline followup visit . Potential participant agree undergo procedure describe protocol . Cognitive impairment : include participant must show sign objective cognitive impairment . Any significant systemic illness unstable medical condition could lead difficulty comply protocol . Illiteracy functional illiteracy . Any contraindication test procedure time study inclusion . Family history monogenic AD . Not willing undergo one test procedure describe protocol baseline .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prevention</keyword>
	<keyword>Cohort Analysis</keyword>
	<keyword>Healthy Participants</keyword>
</DOC>